TC Biopharm (Holdings) PLC Sustainability Reports

TC BioPharm (Holdings) PLC operates as a clinical-stage biopharmaceutical company focused on developing cell therapies and immunotherapy products. The company utilizes a proprietary allogeneic gamma delta T cell platform to target cancer and infectious diseases.

Sector: Manufacturing

Country: United Kingdom

Exchange: OTC Markets

LEI: 5493006WD64125Z37884

No reports are currently available in our catalogue.